Dr. Jiun Kang
My Social Links

Dr. Jiun Kang

Professor
Korea Nazarene University, South Korea


Highest Degree
PostDoc Fellow in Cancer Genetics from Columbia University Medical Center, New York, USA

Share this Profile

Area of Interest:

Molecular Sciences
100%
Cancer Genetics
62%
Cytogenetics
90%
Biochemistry
75%
Oncology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
19
Abstracts
0

Selected Publications

  1. Kang, J.U., 2017. High level amplifications of AKT3, SDCCAG8 and SLC35F3 genes at chromosomal 1q42.2-44 region in non-small cell lung cancer: Early and prognostic implications. Int. J. Cancer Res., 13: 1-8.
  2. Kang, J.U., 2015. Clinical implications of microarray in cancer medicine. Int. J. Cancer Res., 11: 150-158.
  3. Kang, J.U., 2014. Microarray approaches in clinical oncology: Potential and perspectives. Biomed. Sci. Lett., 20: 185-193.
    Direct Link  |  
  4. Kang, J.U., 2014. Chromosome 8q as the most frequent target for amplification in early gastric carcinoma. Oncol. Lett., 7: 1139-1143.
    CrossRef  |  Direct Link  |  
  5. Kang, J.U., 2013. Characterization of amplification patterns and target genes on the short arm of chromosome 7 in early-stage lung adenocarcinoma. Mol. Med. Rep., 8: 1373-1378.
    CrossRef  |  Direct Link  |  
  6. Kang, J.U. and S.H. Koo, 2012. ORAOV1 is a probable target within the 11q13.3 amplicon in lymph node metastases from gastric adenocarcinoma. Int. J. Mol. Med., 29: 81-87.
    CrossRef  |  Direct Link  |  
  7. Kang, J.U. and S.H. Koo, 2012. Evolving applications of microarray technology in postnatal diagnosis. Int. J. Mol. Med., 30: 223-228.
    CrossRef  |  Direct Link  |  
  8. Kang, J.U. and S.H. Koo, 2012. Clinical implementation of chromosomal microarray technology in prenatal diagnosis. Mol. Med. Rep., 6: 1219-1222.
    CrossRef  |  Direct Link  |  
  9. Narayan, G., A.J. Freddy, D. Xie, H. Liyanage and L. Clark et al., 2011. Promoter methylation‐mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance. Genes Chromosomes Cancer, 50: 1043-1053.
    CrossRef  |  Direct Link  |  
  10. Kang, J.U. and S.H. Koo, 2011. Assessment of the beneficial loci and prognostic implications of microsatellite instability in gastric carcinoma. Mol. Med. Rep., 4: 1175-1181.
    CrossRef  |  Direct Link  |  
  11. Kang, J.U., S.H. Koo, K.C. Kwon and J.W. Park, 2010. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung. Int. J. Oncol., 37: 327-335.
    CrossRef  |  Direct Link  |  
  12. Kang, J.U., S.H. Koo, K.C. Kwon and J.W. Park, 2010. AMY2A: A possible tumor-suppressor gene of 1p21.1 loss in gastric carcinoma. Int. J. Oncol., 36: 1429-1435.
    CrossRef  |  Direct Link  |  
  13. Kang, J.U., S.H. Koo, K.C. Kwon, J.W. Park and J.M. Kim, 2009. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer, Vol. 9. 10.1186/1471-2407-9-237.
    CrossRef  |  Direct Link  |  
  14. Kang, J.U., S.H. Koo, K.C. Kwon, J.W. Park and S.S. Jung, 2008. Gain of the EGFR gene located on 7p12 is a frequent and early event in squamous cell carcinoma of the lung. Cancer Genet. Cytogenet., 184: 31-37.
    CrossRef  |  Direct Link  |  
  15. Kang, J.U., S.H. Koo, K.C. Kwon, J.W. Park and J.M. Kim, 2008. Gain at chromosomal region 5p15. 33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet. Cytogenet., 182: 1-11.
    CrossRef  |  Direct Link  |  
  16. Kang, J.U., S.H. Koo, K.C. Kwon, J.W. Park, S.Y. Shin, J.M. Kim and S.S. Jung, 2007. High frequency of genetic alterations in non-small cell lung cancer detected by multi-target fluorescence in situ hybridization. J. Korean Med. Sci., 22: S47-S51.
    CrossRef  |  Direct Link  |  
  17. Kang, J.U., S.H. Koo, T.E. Jeong, K.C. Kwon, J.W. Park and C.H. Jeon, 2006. Multitarget fluorescence in situ hybridization and melanoma antigen genes analysis in primary bladder carcinoma. Cancer Genet. Cytogenet., 164: 32-38.
    CrossRef  |  Direct Link  |  
  18. Kang, J.U., J.J. Kang, K.C. Kwon, J.W. Park, T.E. Jeong, S.M. Noh and S.H. Koo, 2006. Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization. J. Korean Med. Sci., 21: 656-665.
    CrossRef  |  Direct Link  |  
  19. Koo, S.H., T.E. Jeong, J.U. Kang, K.C. Kwon, J.W. Park and S.M. Noh, 2004. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables. Cancer Genet. Cytogenet., 153: 26-31.
    CrossRef  |  Direct Link  |